These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sumatriptan/Naproxen sodium for migraine: efficacy, health related quality of life, and satisfaction outcomes. Smith T, Blumenthal H, Diamond M, Mauskop A, Ames M, McDonald S, Lener S, Burch S. Headache; 2007 May; 47(5):683-92. PubMed ID: 17501849 [Abstract] [Full Text] [Related]
6. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study. Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M. Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050 [Abstract] [Full Text] [Related]
11. Subcutaneous sumatriptan compared with usual acute treatments for migraine: clinical and pharmacoeconomic evaluation. Laloux P, Vakaet A, Monseu G, Jacquy J, Bourgeois P, van der Linden C. Acta Neurol Belg; 1998 Dec; 98(4):332-41. PubMed ID: 9922821 [Abstract] [Full Text] [Related]
12. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L. CNS Drugs; 2005 Dec; 19(2):125-36. PubMed ID: 15697326 [Abstract] [Full Text] [Related]
13. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies. Winner P, Mannix LK, Putnam DG, McNeal S, Kwong J, O'Quinn S, Richardson MS. Mayo Clin Proc; 2003 Oct; 78(10):1214-22. PubMed ID: 14531480 [Abstract] [Full Text] [Related]
14. Sumatriptan nasal spray for migraine: a review of studies in patients aged 17 years and younger. Hämäläinen M, Jones M, Loftus J, Saiers J. Int J Clin Pract; 2002 Nov; 56(9):704-9. PubMed ID: 12469987 [Abstract] [Full Text] [Related]
15. Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types. Ashford E, Salonen R, Saiers J, Woessner M. Cephalalgia; 1998 Jun; 18(5):273-7. PubMed ID: 9673807 [Abstract] [Full Text] [Related]
16. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies. Ryan R, Elkind A, Baker CC, Mullican W, DeBussey S, Asgharnejad M. Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898 [Abstract] [Full Text] [Related]
17. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)]. Scheen AJ. Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347 [No Abstract] [Full Text] [Related]
18. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial. Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M. CNS Drugs; 2003 Sep; 17(11):839-51. PubMed ID: 12921494 [Abstract] [Full Text] [Related]
19. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group. Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168 [Abstract] [Full Text] [Related]
20. Nasal sumatriptan: new dosage. For adolescents with migraine: too little benefit. Prescrire Int; 2005 Apr; 14(76):45-7. PubMed ID: 15875337 [Abstract] [Full Text] [Related] Page: [Next] [New Search]